by Gentaur Laboratory Products
20-200µL Universal Fit |
||
| 2102.N | Biotix | 10/PACK, 5/CASE |
20-200µL Universal Fit |
||
| 2102.S | Biotix | 10/PACK, 5/CASE |
20-200µL Universal Fit |
||
| 2107.N | Biotix | 10/PACK, 10/CASE |
20-200µL Universal Fit |
||
| BT200 | Biotix | 10 trays of 96 / pack |
|
Description: Low retention, Racked, Pre-Sterile, Sample Saving Surface |
||
ProPette™ LE, 20 to 200µL |
||
| P5200-200U | MTC Bio | 1/pack |
|
Description: ProPette LE Single Channel Pipette 20 to 200µL |
||
20-200µL Universal Fit, 192 tip format |
||
| 2101.N | Biotix | 5/PACK, 5/CASE |
ProPette LE 8-Channel Pipette, 20 to 200µL |
||
| P5208-200 | MTC Bio | 1/pack |
|
Description: ProPette LE 8-Channel Pipette 20 to 200µL |
||
ProPette LE 12-Channel Pipette, 20 to 200µL |
||
| P5212-200 | MTC Bio | 1/pack |
|
Description: ProPette LE 12-Channel Pipette 20 to 200µL |
||
Halo™ Single Channel Pipettor, lightweight, 20-200µL |
||
| H6800-200 | MTC Bio | 1 |
ProPette™ LE 8 -Channel Pipette, 20 to 200µL |
||
| P5208-200U | MTC Bio | 1 |
ProPette™ LE 12 -Channel Pipette, 20 to 200µL |
||
| P5212-200U | MTC Bio | 1 |
Retrovirus Booster 200µl |
||
| ABP-RVC-RBST20 | Allele Biotech | 200µl |
200µL Transfer Pipettes |
||
| TP200 | BioAssay Systems | N/A |
Retrovirus Stabilizer 200µl |
||
| ABP-RVC-RSTB20 | Allele Biotech | 200µl |
200µl Olympus Barrier Tip |
||
| 26-412 | Genesee Scientific | 10 Racks of 96 Tips/Unit |
|
Description: Racked, Low Retention, Sterile |
||
200µl Olympus Barrier Tip |
||
| 26-412C | Genesee Scientific | 50 Racks of 96 Tips/Unit |
|
Description: Racked, Low Retention, Sterile |
||
200µl Olympus Premium Barrier Tips |
||
| 23-412 | Genesee Scientific | 10 Racks of 96 Tips/Unit |
|
Description: Low Binding, Racked, Sterile |
||
200µl Olympus Premium Barrier Tips |
||
| 23-412C | Genesee Scientific | 50 Racks of 96 Tips/Unit |
|
Description: Low Binding, Racked, Sterile |
||
CD64, 10.1; IgG1; Purified; 200µg/200µl |
||
| M853483020 | Tecan Benelux | 1 unit |
200µL BLACK NON-CONDUCTIVE ROBOTIC TIPS |
||
| RMT-200-BK-R | CORNING | 960/pk |
|
Description: Robotic Tips; Robotic tips - Axygen |
||
CD9, TS9; IgG1; Azide free; 200µg/200µl |
||
| M857750000 | Tecan Benelux | 1 unit |
CD53, TS53; IgG1; Azide free; 200µg/200µl |
||
| M857760000 | Tecan Benelux | 1 unit |
CD63, TS63; IgG1; Azide free; 200µg/200µl |
||
| M857770000 | Tecan Benelux | 1 unit |
CD82, TS82b; IgG1; Azide free; 200µg/200µl |
||
| M857790000 | Tecan Benelux | 1 unit |
OZ Biosciences ViroMag R/L 200µl - EACH |
||
| RL40200 | Scientific Laboratory Supplies | EACH |
CD5, B-B8; IgG1; Azide free; 200µg/200µl |
||
| M854040000 | Tecan Benelux | 1 unit |
CD6, B-F3; IgG1; Azide free; 200µg/200µl |
||
| M854050000 | Tecan Benelux | 1 unit |
CD75, B-L5; IgM; Azide free; 200µg/200µl |
||
| M854420000 | Tecan Benelux | 1 unit |
CD25 , B-G3; IgG1; Azide free; 200µg/200µl |
||
| M852020000 | Tecan Benelux | 1 unit |
CD2, B-E2; IgG2b; Azide free; 200µg/200µl |
||
| M852500000 | Tecan Benelux | 1 unit |
Gentaur PCR Products
Cl-PEG3-Cl |
||
| abx085210-200l | Abbexa | 200 µl |
BMS-202 |
||
| 561499 | MedKoo Biosciences | 5.0mg |
4SC-202 |
||
| 205800 | MedKoo Biosciences | 10.0mg |
4SC-202 |
||
| B4106-10 | ApexBio | 10 mg |
|
Description: Chromatin/Epigenetics|HDAC |
||
4SC-202 |
||
| B4106-100 | ApexBio | 100 mg |
|
Description: Chromatin/Epigenetics|HDAC |
||
4SC-202 |
||
| B4106-5 | ApexBio | 5 mg |
|
Description: Chromatin/Epigenetics|HDAC |
||
4SC-202 |
||
| B4106-50 | ApexBio | 50 mg |
|
Description: Chromatin/Epigenetics|HDAC |
||
ML 202 |
||
| B5739-10 | ApexBio | 10 mg |
4SC-202 |
||
| B1230-25 | Biovision | each |
4SC-202 |
||
| B1230-5 | Biovision | each |
BMS-202 |
||
| abx283129-100g | Abbexa | 100 µg |
BMS-202 |
||
| abx283129-20g | Abbexa | 20 µg |
BMS-202 |
||
| abx283129-50g | Abbexa | 50 µg |
SR 202 |
||
| B6929-10 | ApexBio | 10mg |
|
Description: Metabolism|PPAR |
||
SR 202 |
||
| B6929-5 | ApexBio | 5 mg |
|
Description: IC50: 140 ?M for attenuation of troglitazone-induced peroxisome proliferator-activated receptor gamma (PPAR) transcriptional activity. |
||
SR 202 |
||
| B6929-50 | ApexBio | 50mg |
|
Description: Metabolism|PPAR |
||
4SC-202 |
||
| MBS132899-INQUIRE | MyBiosource | INQUIRE |
4SC-202 |
||
| MBS130310-100mg | MyBiosource | 100mg |
4SC-202 |
||
| MBS130310-500mg | MyBiosource | 500mg |
BMS-202 |
||
| HY-19745 | MedChemExpress | 100mg |
|
Description: BMS-202 is a potent and nonpeptidic PD-1/PD-L1 complex inhibitor with an IC50 of 18 nM and a KD of 8 μM. BMS-202 binds to PD-L1 and blocks human PD-1/PD-L1 interaction. BMS-202 has antitumor activity[1][2]. |
||
LYG-202 |
||
| HY-115436 | MedChemExpress | 10 mg |
|
Description: LYG-202, a flavonoid, has potent anti-angiogenic and antitumor activity. LYG-202 inhibits VEGF-stimulated HUVEC migration and tube formation. LYG-202 induces cancer cell apoptosis[1][2]. |
||
Kih 202 |
||
| MBS5781965-5mg | MyBiosource | 5(mg |
Kih 202 |
||
| MBS5781965-5x5mg | MyBiosource | 5x5(mg |
ABT-202 |
||
| MBS5779160-5mg | MyBiosource | 5(mg |
ABT-202 |
||
| MBS5779160-5x5mg | MyBiosource | 5x5(mg |
4SC-202 |
||
| MBS385200-10mg | MyBiosource | 10mg |
4SC-202 |
||
| MBS385200-1mLinDMSO | MyBiosource | 1mL(inDMSO) |
4SC-202 |
||
| MBS385200-25mg | MyBiosource | 25mg |
4SC-202 |
||
| MBS385200-50mg | MyBiosource | 50mg |
4SC-202 |
||
| MBS385200-5x50mg | MyBiosource | 5x50mg |
BMS-202 |
||
| MBS3602560-10mg | MyBiosource | 10mg |
BMS-202 |
||
| MBS3602560-25mg | MyBiosource | 25mg |
BMS-202 |
||
| MBS3602560-2mg | MyBiosource | 2mg |
BMS-202 |
||
| MBS3602560-50mg | MyBiosource | 50mg |
BMS-202 |
||
| MBS3602560-5mg | MyBiosource | 5mg |
Antibiotic-202 |
||
| MBS579983-10mg | MyBiosource | 10mg |
Antibiotic-202 |
||
| MBS579983-1mg | MyBiosource | 1mg |
Antibiotic-202 |
||
| MBS579983-25mg | MyBiosource | 25mg |
Antibiotic-202 |
||
| MBS579983-50mg | MyBiosource | 50mg |
Antibiotic-202 |
||
| MBS579983-5mg | MyBiosource | 5mg |
LYG-202 |
||
| MBS5797623-50mg | MyBiosource | 50(mg |
LYG-202 |
||
| MBS5797623-5x50mg | MyBiosource | 5x50(mg |
miR-202 |
||
| PO-0107 | Signosis | 20 |
miR-202 |
||
| MP-0084 | Signosis | 20 |
miR-202 |
||
| MO-0084 | Signosis | 100 |
PBDE 202 |
||
| P215290 | Toronto Research Chemicals | 100mg |
|
Description: 67797-09-5 |
||
RGX-202 |
||
| T7535-10mg | TargetMol Chemicals | 10mg |
|
Description: RGX-202 |
||
RGX-202 |
||
| T7535-1g | TargetMol Chemicals | 1g |
|
Description: RGX-202 |
||
RGX-202 |
||
| T7535-1mg | TargetMol Chemicals | 1mg |
|
Description: RGX-202 |
||
RGX-202 |
||
| T7535-50mg | TargetMol Chemicals | 50mg |
|
Description: RGX-202 |
||
RGX-202 |
||
| T7535-5mg | TargetMol Chemicals | 5mg |
|
Description: RGX-202 |
||
BMS-202 |
||
| T3146-10mg | TargetMol Chemicals | 10mg |
|
Description: BMS-202 |
||
BMS-202 |
||
| T3146-1g | TargetMol Chemicals | 1g |
|
Description: BMS-202 |
||
BMS-202 |
||
| T3146-1mg | TargetMol Chemicals | 1mg |
|
Description: BMS-202 |
||
BMS-202 |
||
| T3146-50mg | TargetMol Chemicals | 50mg |
|
Description: BMS-202 |
||
BMS-202 |
||
| T3146-5mg | TargetMol Chemicals | 5mg |
|
Description: BMS-202 |
||
Kih 202 |
||
| T32396-10mg | TargetMol Chemicals | 10mg |
|
Description: Kih 202 |
||
